Company

Cancer’s Vulnerability is Our Strength

MANAGEMENT

Markus Renschler, MDPresident & Chief Executive Officer

Susan DolemanVP, Clinical Operations

Paul Secrist, Ph.D. Chief Scientific Officer

Barbara Wan, PhDVP, Research & Development Project Leadership

Tom O'Shea, PhDSVP, Clinical Pharmacology & Preclinical Development

Judson Englert, M.D., Ph.D.VP, Clinical Research & Development

Jean-Marc Lapierre, PhDVP, Chemistry

Andrew GengosChief Business Officer

Racquel BrackenVenrock

Markus Renschler, MDPresident & Chief Executive Officer

Jean George, MBALightstone Ventures

Timothy RombergerFounder Cyteir Therapeutics & TRC Advisory

Joseph S. ZakrzewskiIndependent Investor & Chairman, Cyteir Therapeutics

Karen Hong, PhDNovo Ventures

Janwillem Naesens, MSc, MBADROIA